Legend Biotech Corp Cash Flows From Used In Operations Before Changes In Working Capital
Legend Biotech Corp (LEGN) reported Cash Flows From Used In Operations Before Changes In Working Capital of -$40.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital · last filed 2026-03-10
- Legend Biotech Corp cash flows from used in operations before changes in working capital for the quarter ending 2025-12-31 was $9.28M.
- Legend Biotech Corp cash flows from used in operations before changes in working capital for the quarter ending 2025-09-30 was -$20.81M.
- Legend Biotech Corp cash flows from used in operations before changes in working capital for the quarter ending 2025-06-30 was $3.52M.
- Legend Biotech Corp cash flows from used in operations before changes in working capital for the quarter ending 2025-03-31 was -$32.70M.
| Period end | Cash Flows From Used In Operations Before Changes In Working Capital 3 month | Cash Flows From Used In Operations Before Changes In Working Capital 3 month as first filed | Cash Flows From Used In Operations Before Changes In Working Capital 6 month | Cash Flows From Used In Operations Before Changes In Working Capital 6 month as first filed | Cash Flows From Used In Operations Before Changes In Working Capital 9 month | Cash Flows From Used In Operations Before Changes In Working Capital 9 month as first filed | Cash Flows From Used In Operations Before Changes In Working Capital 12 month | Cash Flows From Used In Operations Before Changes In Working Capital 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $9.28M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$11.52M derived: sum of 2 quarters · filed 2026-03-10 | -$8.00M derived: sum of 3 quarters · filed 2026-03-10 | -$40.70M 20-F · filed 2026-03-10 | ||||
| 2025-09-30 | -$20.81M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -$17.29M derived: sum of 2 quarters · filed 2025-11-12 | -$49.98M 6-K · filed 2025-11-12 | -$97.98M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-06-30 | $3.52M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$29.18M 6-K · filed 2025-08-11 | -$77.17M derived: sum of 3 quarters · filed 2026-03-10 | -$126.32M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-03-31 | -$32.70M 6-K · filed 2025-05-13 | -$80.69M derived: sum of 2 quarters · filed 2026-03-10 | -$129.84M derived: sum of 3 quarters · filed 2026-03-10 | -$139.14M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-12-31 | -$48.00M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$97.14M derived: sum of 2 quarters · filed 2026-03-10 | -$106.44M derived: sum of 3 quarters · filed 2026-03-10 | -$198.10M 20-F · filed 2026-03-10 | -$198.17M 20-F · filed 2025-03-11 | |||
| 2024-09-30 | -$49.15M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -$58.44M derived: sum of 2 quarters · filed 2025-11-12 | -$150.10M 6-K · filed 2025-11-12 | -$187.61M 6-K · filed 2024-11-12 | -$249.88M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-06-30 | -$9.29M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$100.96M 6-K · filed 2025-08-11 | -$121.42M 6-K · filed 2024-08-09 | -$200.74M derived: sum of 3 quarters · filed 2026-03-10 | -$274.89M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-03-31 | -$91.66M 6-K · filed 2025-05-13 | -$103.84M 6-K · filed 2024-05-13 | -$191.44M derived: sum of 2 quarters · filed 2026-03-10 | -$265.60M derived: sum of 3 quarters · filed 2026-03-10 | -$348.75M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2023-12-31 | -$99.78M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$173.94M derived: sum of 2 quarters · filed 2026-03-10 | -$257.08M derived: sum of 3 quarters · filed 2026-03-10 | -$368.20M 20-F · filed 2026-03-10 | -$368.14M 20-F · filed 2024-03-19 | |||
| 2023-09-30 | -$74.16M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$157.31M derived: sum of 2 quarters · filed 2024-11-12 | -$268.42M 6-K · filed 2024-11-12 | -$269.76M 6-K · filed 2023-11-20 | -$375.62M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-06-30 | -$83.15M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$194.26M 6-K · filed 2024-08-09 | -$194.84M 6-K · filed 2023-08-15 | -$301.46M derived: sum of 3 quarters · filed 2025-03-11 | -$430.85M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-03-31 | -$111.12M 6-K · filed 2024-05-13 | -$218.31M derived: sum of 2 quarters · filed 2025-03-11 | -$347.70M derived: sum of 3 quarters · filed 2025-03-11 | |||||
| 2022-12-31 | -$107.19M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | -$236.59M derived: sum of 2 quarters · filed 2025-03-11 | -$397.25M 20-F · filed 2025-03-11 | -$402.54M 20-F · filed 2023-03-30 | ||||
| 2022-09-30 | -$129.39M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$290.06M 6-K · filed 2023-11-20 | ||||||
| 2022-06-30 | -$160.67M 6-K · filed 2023-08-15 | |||||||
| 2021-12-31 | -$361.45M 20-F · filed 2024-03-19 | -$340.48M 20-F · filed 2022-03-31 | ||||||
| 2021-06-30 | -$154.80M 6-K · filed 2021-08-23 | |||||||
| 2020-12-31 | -$212.50M 20-F · filed 2023-03-30 | -$211.82M 20-F · filed 2021-04-02 | ||||||
| 2020-06-30 | -$94.74M 6-K · filed 2021-08-23 | |||||||
| 2019-12-31 | -$126.20M 20-F/A · filed 2023-02-17 | -$128.92M 20-F · filed 2021-04-02 | ||||||
| 2018-12-31 | -$12.75M 20-F · filed 2021-04-02 |